PCI are an integrated full service pharmaceutical provider. Our molecule to market offering takes compounds from the earliest stages of development through to commercial launch, delivering speed to market and commercial success for our customers.

Our core services include: Analytical services, formulation development, clinical trial supply, commercial manufacturing and packaging, QP services, supply chain management, storage and distribution. Our facilities and capability enable the safe development, clinical and commercial supply of potent products with an OEL down to 0.01 μg/m³. Customers can choose to use us as a complete development partner or choose any of our core services as a stand-alone offering.  

Our comprehensive pharmaceutical development service includes early stage formulation and analytical development, drug in capsule/vial using Xcelodose® technology, scale-up and process validation, technology transfer and all associated analytical support services.  By involving our experts early in the...

Related Categories

Sales Markets

Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Africa; Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)

Primary business activity

Contract Service